Harbin Pharmaceutical Group Co

Harbin Pharmaceutical Group Co Book Value per Share

The Book Value per Share of Harbin Pharmaceutical Group Co (600664.SS) as of Oct 28, 2026 is 2.26 CNY. In the previous year, Book Value per Share was 2.12 CNY — a change of 6.32% (higher).

Book Value per Share

2.26CNY

YoY

6.32%

Last updated:

Book Value per Share of Harbin Pharmaceutical Group Co is 2025 2.26 CNY. Book Value per Share of Harbin Pharmaceutical Group Co was 2024 2.12 CNY. It decreases by 6.32% higher compared to the previous year.

The Harbin Pharmaceutical Group Co Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2018
2.33 CNY
Jan 1, 2019
2.17 CNY
Jan 1, 2020
1.38 CNY
Jan 1, 2021
1.53 CNY
Jan 1, 2022
1.72 CNY
Jan 1, 2023
1.88 CNY
Jan 1, 2024
2.12 CNY
Jan 1, 2025
2.26 CNY
The Harbin Pharmaceutical Group Co Book Value per Share history
YEARBook Value per ShareYoY
2.26CNY+6.32%
2.12CNY+13.24%
1.88CNY+9.07%
1.72CNY+12.58%
1.53CNY+10.56%
1.38CNY-36.23%
2.17CNY-6.97%
2.33CNY-16.82%
2.80CNY-10.20%
3.12CNY+11.34%
2.80CNY-14.39%
3.27CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Harbin Pharmaceutical Group Co Stock analysis

What does Harbin Pharmaceutical Group Co do? Harbin Pharmaceutical Group Co., Ltd. generates revenue by engaging in the research, development, manufacture, wholesale, and retail of pharmaceutical products. The firm focuses on innovative research and development in high-tech fields such as antibiotics, modern Chinese medicine, and biopharmaceuticals. These activities support its main business sectors, which include antibiotics, over-the-counter drugs and health products, traditional and modern Chinese medicine, biomedicine, and pharmaceutical commerce. The company produces a wide range of items, including calcium gluconate oral solution, zinc gluconate oral solution, amoxicillin capsules, Shuanghuanglian oral solution, alprostadil injection, pediatric paracetamol Huangnamin granules, lacidipine tablets, hydrochloric acid for injection Cefotiam, ibuprofen granules, and Xingaizhonggai high calcium tablets. The business is structured around these diverse product lines, serving the needs of the pharmaceutical commerce sector and consumers requiring specific medical treatments. By covering the entire value chain from research and development to retail, the company monetizes its expertise in high-tech fields. The products listed, such as Shuanghuanglian oral solution and amoxicillin capsules, represent the tangible outputs of its manufacturing and wholesale operations, which are central to its financial model. Harbin Pharmaceutical Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harbin Pharmaceutical Group Co stock

Book Value per Share of Harbin Pharmaceutical Group Co is 2.26 CNY in 2025.

Book Value per Share of Harbin Pharmaceutical Group Co changed from 2.12 CNY to 2.26 CNY, representing a 6.32% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Harbin Pharmaceutical Group Co since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Harbin Pharmaceutical Group Co

All Key Metrics — Harbin Pharmaceutical Group Co